Author:
Abrahamovych M. O., ,Abrahamovych O. O.,Fayura O. P.,Fayura L. R, , ,
Publisher
Petro Mohyla Black Sea National University
Reference31 articles.
1. Abrahamovych MO, Abrahamovych OO, Faiura OP, Tolopko SY, Ferko MR. Umist deiakykh endoteliizalezhnykh vazoaktyvnykh substantsii u krovi khvorykh zalezhno vid tiazhkosti tsyrozu pechinky ta stanu redoks-systemy organizmu. Lvivskyi klinichnyi visnyk. 2019; 4(28): 18-27. [Ukrainian]. https://doi.org/10.25040/lkv2019.04.014
2. Abrahamovych MO, Abrahamovych OO. Klasyfikatsiia tsyrozu pechinky: retrospektyvnyi pohliad na problemu ta suchasne yii vyrishennia z urakhuvanniam syntropichnykh ko- ta polimorbidnykh urazhen khvoroho. Medytsyna transportu Ukrainy. 2013; 2: 10-6. [Ukrainian]
3. Abrahamovych O, Abrahamovych M, Tolopko S, Fayura O, Ferko M. Character and Frequency of the Variations of Co- and Polymorbid Syntropic Extrahepatic Lesions and Their Dependence on the Hepatopulmonary Syndrome Severity Degree in Cirrhotic Patients. Georgian Medical News. 2016; 1(260): 34-41.
4. Alexander V, Ivanov O, Khomich А, Birke B. Oxidative Stress in Hepatitis C Infection. The Liver. Oxid Stress Diet Antioxidants. 2018: 1-13. https://www.ncbi.nlm.nih.gov/pubmed/23358390. https://www.ncbi.nlm.nih.gov/pmc/articles/3640510. https://doi.org/10.3390/v5020439
5. Assimakopoulos SF, Gogos C, Lambropoulou-Karatza C. Could antioxidants be the "magic pill" for cirrhosis-related complications? A pathophysiological appraisal. Med Hypotheses. 2011; 77: 419-23. https://www.ncbi.nlm.nih.gov/pubmed/21703771. https://doi.org/10.1016/j.mehy.2011.05.034